For the newborn, the neonatal period is a physiologic transition from maternal-dependence to self-reliance. At this time the immune system faces the challenge of relocating from the sterile intra-utero milieu to a world of allergens and microbes where protection is critical. Yet, injection of antigen during the neonatal stage often leads to tolerance, and only a few vaccines work in human neonates. Initially, deletion and/or inactivation of T cells were considered the leading mechanisms for neonatal tolerance. However, recent investigations have revealed that the neonatal immune system can be regulated and guided to develop T cell immunity. For instance, if a peptide is injected into neonates in adjuvant immunity develops. The essence of this observation is that approaches can be devised that could force the neonatal immune system to be responsive, providing an opportunity to analyze and comprehend its mode of action. The objectives in this application seek to enlighten our comprehension of this understudied area of neonatal immunity. Both cellular and molecular aspects of neonatal immunity will be examined. The application under consideration employs a novel approach to trigger neonatal immunity, and the preliminary studies outline a unique mechanism the neonatal immune system utilizes to control T cells. This approach uses genetically engineered immunoglobulins (Igs) incorporating antigenic peptides as vehicles for delivery of such peptides into antigen presenting cells and stimulation of T cells. The rational for this delivery system is that it increases peptide presentation by several orders of magnitude relative to free peptide and involves regulatory functions influential for costimulation and T cell differentiation. Indeed, when an Ig-peptide chimera was given to mice in saline on the day of birth it induced a neonatal immunity that protected animals against the development of the autoimmune disease known as experimental allergic encephalomyelitis. Herein, we propose to investigate the mechanism underlying such protective neonatal immunity and hopefully enlighten our comprehension of neonatal immunity. Understanding how the neonatal immune system functions is a prerequisite for the development of neonatal vaccines.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI048541-05
Application #
6732104
Study Section
Immunological Sciences Study Section (IMS)
Program Officer
Macchiarini, Francesca
Project Start
2001-05-01
Project End
2006-04-30
Budget Start
2004-05-01
Budget End
2005-04-30
Support Year
5
Fiscal Year
2004
Total Cost
$251,537
Indirect Cost
Name
University of Missouri-Columbia
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
153890272
City
Columbia
State
MO
Country
United States
Zip Code
65211
Ellis, Jason S; Guloglu, F Betul; Zaghouani, Habib (2016) Presentation of high antigen-dose by splenic B220(lo) B cells fosters a feedback loop between T helper type 2 memory and antibody isotype switching. Immunology 147:464-75
Dhakal, Mermagya; Miller, Mindy M; Zaghouani, Adam A et al. (2015) Neonatal Basophils Stifle the Function of Early-Life Dendritic Cells To Curtail Th1 Immunity in Newborn Mice. J Immunol 195:507-18
Dhakal, Mermagya; Hardaway, John C; Guloglu, Fatma Betul et al. (2014) IL-13R?1 is a surface marker for M2 macrophages influencing their differentiation and function. Eur J Immunol 44:842-55
Guloglu, F Betul; Ellis, Jason S; Wan, Xiaoxiao et al. (2013) Antigen-free adjuvant assists late effector CD4 T cells to transit to memory in lymphopenic hosts. J Immunol 191:1126-35
Hoeman, Christine M; Dhakal, Mermagya; Zaghouani, Adam A et al. (2013) Developmental expression of IL-12R?2 on murine naive neonatal T cells counters the upregulation of IL-13R?1 on primary Th1 cells and balances immunity in the newborn. J Immunol 190:6155-63
Haymaker, Cara L; Guloglu, F Betul; Cascio, Jason A et al. (2012) Bone marrow-derived IL-13Rýý1-positive thymic progenitors are restricted to the myeloid lineage. J Immunol 188:3208-16
Ellis, Jason S; Guloglu, F Betul; Tartar, Danielle M et al. (2010) APCs expressing high levels of programmed death ligand 2 sustain the development of CD4 T cell memory. J Immunol 185:3149-57
Zaghouani, Habib; Hoeman, Christine M; Adkins, Becky (2009) Neonatal immunity: faulty T-helpers and the shortcomings of dendritic cells. Trends Immunol 30:585-91
Yu, Ping; Haymaker, Cara L; Divekar, Rohit D et al. (2008) Fetal exposure to high-avidity TCR ligand enhances expansion of peripheral T regulatory cells. J Immunol 181:73-80
Lee, Hyun-Hee; Hoeman, Christine M; Hardaway, John C et al. (2008) Delayed maturation of an IL-12-producing dendritic cell subset explains the early Th2 bias in neonatal immunity. J Exp Med 205:2269-80

Showing the most recent 10 out of 17 publications